Closed |
S0030 |
COLORECTAL |
2/1/2003 |
2/1/2005 |
48% |
|
Published
|
Closed |
S0031 |
Advanced Bladder |
2/15/2001 |
10/15/2002 |
56% |
|
Published
|
Closed |
S0032 |
Advanced Prostate |
12/1/2001 |
6/1/2005 |
48% |
|
Published
|
Closed |
S0033 |
Gastrointestinal Stromal Tumor |
12/15/2000 |
9/1/2001 |
100% |
|
Published
|
Closed |
S0101 |
ESOPHAGEAL |
4/15/2001 |
2/1/2003 |
100% |
|
Published
|
Closed |
S0102 |
ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Neg Stage IV Breast Cancer |
5/1/2001 |
1/1/2004 |
100% |
|
Published
|
Closed |
S0106 |
Phase III Starndard + Mylotarg vs. Standard + Daunomycin/Ara-C for AML Under Age 61 |
5/15/2004 |
8/20/2009 |
93% |
|
Published
|
Closed |
S0107 |
PANCREAS |
7/1/2001 |
6/1/2003 |
100% |
|
Published
|
Closed |
S0108 |
NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL |
4/15/2001 |
12/1/2004 |
87% |
|
Published
|
Closed |
S0109 |
Advanced Renal |
5/1/2001 |
2/1/2002 |
100% |
|
Published
|
Closed |
S0111 |
Advanced Prostate |
6/15/2001 |
11/15/2003 |
100% |
|
Published
|
Closed |
S0112 |
Elderly AML |
8/1/2001 |
4/1/2003 |
100% |
|
Published
|
Closed |
S0115 |
Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study |
1/1/2004 |
10/15/2010 |
95% |
|
Published
|
Closed |
S0119 |
Gemcitabine/Irinotecan Untreated Extensive SCLC |
1/1/2002 |
2/15/2003 |
100% |
|
Published
|
Closed |
S0120 |
Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders |
6/1/2002 |
4/1/2011 |
97% |
|
Published
|
Closed |
S0124 |
Cis/Irinotecan vs. Cis/VP-16 in Extensive SCLC |
11/1/2002 |
3/1/2007 |
99% |
|
Published
|
Closed |
S0126 |
ZD1839/BAC/Previously-Untreated & Previously-Treated; Selected IIIB & IV |
12/1/2001 |
7/1/2003 |
100% |
|
Published
|
Closed |
S0127 |
GASTRIC AND GE JUNCTION |
6/1/2002 |
8/15/2003 |
88% |
|
Published
|
Closed |
S0200 |
OVARIAN |
8/15/2002 |
12/15/2004 |
6% |
|
Published
|
Closed |
S0202 |
GALLBLADDER AND CHOLANGIOCARCINOMA |
9/1/2003 |
4/1/2005 |
100% |
|
Published
|